Cargando…
Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
BACKGROUND: Globally, stomach adenocarcinoma (STAD)’s high morbidity and mortality should arouse our urgent attention. How long can STAD patients survive after surgery and whether novel immunotherapy is effective are questions that our clinicians cannot escape. METHODS: Various R packages, GSEA soft...
Autores principales: | Yue, Taohua, Zuo, Shuai, Zhu, Jing, Guo, Shihao, Huang, Zhihao, Li, Jichang, Wang, Xin, Liu, Yucun, Chen, Shanwen, Wang, Pengyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369372/ https://www.ncbi.nlm.nih.gov/pubmed/34414187 http://dx.doi.org/10.3389/fcell.2021.704242 |
Ejemplares similares
-
BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients
por: Yue, Taohua, et al.
Publicado: (2022) -
The aging-related risk signature in colorectal cancer
por: Yue, Taohua, et al.
Publicado: (2021) -
Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer
por: Yue, Taohua, et al.
Publicado: (2020) -
Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022) -
Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)